Approach to Intestinal Failure in Children.
A review the available evidence supporting recent advances in care for children with intestinal failure.
A review the available evidence supporting recent advances in care for children with intestinal failure.
The objective was to compare the aspartate aminotransferase to platelet ratio index, liver transplantation, and mortality rates between children with intestinal failure-associated liver disease who received fish oil lipid emulsion or soybean oil intravenous lipid emulsion.
The aim was to identify patients with advanced fibrosis using a noninvasive index and to study the risk factors for fibrosis development in the Sustain registry.
The aim of the study was to evaluate the ability of non-invasive liver function tests to assess liver function following the initiation of parenteral nutrition.
We present a case whereby modification of contributing factors, such as lipid preparations, led to improvements in intestinal failure associated liver disease and reversal of hepatic fibrosis.
Retrospective review in pediatric intestinal failure patients who received Omegaven, had liver biopsies completed before Omegaven therapy and after resolution of hyperbilirubinemia.
The objective was to determine the evolution of hepatic fibrosis in pediatric intestinal failure patients who received Omegaven along with a description of their clinical outcome.